Preston Klassen, EVP, Global Development at Orexigen, holds 10.16K shares in Orexigen (Ticker: OREXQ), holds 3.99K shares in Arena Pharma (Ticker: ARNA), holds 1.38M shares in Metacrine (Ticker: MTCR).
Preston Klassen latest transaction was an Uninformative Buy of $16.22K.
What was Preston Klassen's most profitable transaction?
Preston Klassen’s most profitable transaction was an Informative Sell of MTCR stock on April 20, 2022. The return on the trade was -6.50%.
What is Preston Klassen's role in Orexigen?
Preston Klassen's role in Orexigen is EVP, Global Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.